EDGE News

Home, home below the range: all five deals this week priced below the range.  There were eleven companies on the IPO calendar this week, but only five were able to price, and each of those priced at least 19% below their...read more

Edge Therapeutics, which is developing a sustained-release therapy for limiting brain injury after aneurysms, raised $80 million by offering 7.3 million shares at $11, far below the range of $14 to $16. Edge Therapeutics plans to list on the Nasdaq under the symbol EDGE. Edge Therapeutics initially filed confidentially on 3/21/2014. Leerink Partners and Credit Suisse acted as...read more

The last week of September has 11 IPOs on the calendar – more IPOs than all of August 2015.  Out of 134 offerings so far in 2015, 61 have been health care companies. Next week, 7 out of the 11 IPOs on the calendar are health care. A large foodservice distributor and three...read more

Edge Therapeutics, which is developing a sustained-release therapy for ruptured brain aneurysms, announced terms for its IPO on Monday. The Berkeley Heights, NJ-based company plans to raise $85 million by offering 5.7 million shares at a price range of $14 to $16. At the midpoint of the proposed range, Edge Therapeutics would command a fully diluted market value of $435 million...read more